Current Report Filing (8-k)
17 Mai 2023 - 2:36PM
Edgar (US Regulatory)
0001686850
false
0001686850
2023-05-17
2023-05-17
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 17, 2023
MOTUS
GI HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-38389 |
|
81-4042793 |
(State
or other jurisdiction |
|
(Commission
|
|
(IRS
Employer |
of
incorporation) |
|
File
Number) |
|
Identification
No.) |
1301
East Broward Boulevard, 3rd Floor
Ft.
Lauderdale, FL |
|
33301 |
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (954) 541-8000
Not
Applicable
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐ |
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities
registered pursuant to Section 12(b) of the Act:
Title
of Each Class |
|
Trading
Symbol(s) |
|
Name
of Each Exchanged on Which Registered |
Common
Stock, $0.0001 par value per share |
|
MOTS |
|
The
Nasdaq Capital Market |
Item
7.01. Regulation FD.
On
May 17, 2023, Motus GI Holdings, Inc. (the “Company”) issued a press release announcing the initiation of a clinical evaluation
of the Pure-Vu Gen 4 Gastro, which is designed for upper gastrointestinal (GI) bleeding procedures, in collaboration with the Ecuadorian
Institute of Digestive Diseases (IECED). A copy of the press release is attached hereto as Exhibit 99.1.
The
information in this Current Report on Form 8-K under Item 7.01, including the information contained in Exhibit 99.1, is being furnished
to the Securities and Exchange Commission, and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall
not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by a specific reference in such filing.
Item
8.01 Other Events.
On
May 17, 2023, the Company issued a press release announcing the initiation of a clinical evaluation of the Pure-Vu Gen 4 Gastro, which
is designed for upper GI bleeding procedures, in collaboration with the IECED. The Pure-Vu Gen 4 Gastro builds off the success of the
patented and proprietary pulsed vortex irrigation and smart sense suction used in the colon device, and has been enhanced to target blood
and blood clots in the upper GI tract. The system has been further streamlined to allow for easy navigation through the GI tract and
allows the physician to grip the endoscope directly so that there is virtually no ergonomic impact in performing a procedure.
Item
9.01. Financial Statements and Exhibits.
(d)
The following exhibit is furnished with this report:
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
MOTUS
GI HOLDINGS, INC. |
|
|
|
Dated:
May 17, 2023 |
By:
|
/s/
Mark Pomeranz |
|
Name:
|
Mark
Pomeranz |
|
Title: |
Chief
Executive Officer |
Motus GI (NASDAQ:MOTS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Motus GI (NASDAQ:MOTS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024